Cognition Therapeutics, Inc. (CGTX)
Total Valuation
CGTX has a market cap or net worth of $70.98 million. The enterprise value is $41.75 million.
Market Cap | 70.98M |
Enterprise Value | 41.75M |
Important Dates
The last earnings date was Tuesday, March 26, 2024, before market open.
Earnings Date | Mar 26, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CGTX has 39.00 million shares outstanding. The number of shares has increased by 27.03% in one year.
Shares Outstanding | 39.00M |
Shares Change (YoY) | +27.03% |
Shares Change (QoQ) | +2.18% |
Owned by Insiders (%) | 6.50% |
Owned by Institutions (%) | 34.20% |
Float | 24.68M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.90 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.37, with a Debt / Equity ratio of 0.03.
Current Ratio | 3.37 |
Quick Ratio | n/a |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -954.11 |
Financial Efficiency
Return on equity (ROE) is -83.50% and return on invested capital (ROIC) is -201.54%.
Return on Equity (ROE) | -83.50% |
Return on Assets (ROA) | -63.10% |
Return on Capital (ROIC) | -201.54% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.17M |
Employee Count | 22 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.78% in the last 52 weeks. The beta is 1.66, so CGTX's price volatility has been higher than the market average.
Beta (1Y) | 1.66 |
52-Week Price Change | -10.78% |
50-Day Moving Average | 2.07 |
200-Day Moving Average | 1.71 |
Relative Strength Index (RSI) | 42.00 |
Average Volume (30 Days) | 213,070 |
Short Selling Information
The latest short interest is 228,126, so 0.58% of the outstanding shares have been sold short.
Short Interest | 228,126 |
Short Previous Month | 126,747 |
Short % of Shares Out | 0.58% |
Short % of Float | 0.92% |
Short Ratio (days to cover) | 0.67 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -50.72M |
Pretax Income | -25.79M |
Net Income | -25.79M |
EBITDA | -25.51M |
EBIT | -25.76M |
Earnings Per Share (EPS) | -$0.86 |
Balance Sheet
The company has $29.92 million in cash and $694,000 in debt, giving a net cash position of $29.23 million or $0.75 per share.
Cash & Cash Equivalents | 29.92M |
Total Debt | 694,000 |
Net Cash | 29.23M |
Net Cash Per Share | $0.75 |
Equity / Book Value | 24.47M |
Book Value Per Share | 0.63 |
Working Capital | 24.05M |
Cash Flow
In the last 12 months, operating cash flow was -$16.02 million and capital expenditures -$147,000, giving a free cash flow of -$16.17 million.
Operating Cash Flow | -16.02M |
Capital Expenditures | -147,000 |
Free Cash Flow | -16.17M |
FCF Per Share | -$0.54 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CGTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -27.03% |
Shareholder Yield | -27.03% |
Earnings Yield | -36.33% |
FCF Yield | -22.77% |
Analyst Forecast
The average price target for CGTX is $6.67, which is 266.48% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $6.67 |
Price Target Difference | 266.48% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |